Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry

American Journal of Hypertension

Volumn 17, Issue 5, 2004, Pages 428-432

  Libhaber, Elena N ^a   Libhaber, Carlos D ^b   Candy, Geoffrey P ^b   Sliwa, Karen ^b   Kachope, John ^b   Hlatshwayo, Ntombi M ^b   Puane, Mapenene O ^b   Woodiwiss, Angela J ^b   Norton, Gavin R ^b   Essop, Mohamed R ^b   Sareli, Pinchas ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NONE

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive agents; Blacks; Indapamide

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; INDAPAMIDE; PERINDOPRIL;

ADULT; AFRICA; AGED; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG RELEASE; FEMALE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLOW RELEASE FORMULATION; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; DIASTOLE; DIURETICS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INDAPAMIDE; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES; SOUTH AFRICA; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME;

EID: 11144354134     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.02.010     Document Type: Article

References (11)

1. Hypertension Society of Southern Africa, endorsed by the Medical Association of South Africa and the Medical Research Council. Guidelines for the management of hypertension at primary health care level. S Afr Med J. 91:2001;161-172.
2. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7 Report). JAMA. 289:2003;2560-2572.
3. Sareli P., Radevski I.V., Valtchanova Z.P., Libhaber E., Candy G.P., Den Hond E., Libhaber C.D., Skudicky D., Wang J.G.G., Staessen J.A. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects. Results of a Randomized Trial in Johannesburg, South Africa. Arch Intern Med. 161:2001;965-971.
4. Radevski I.V., Valtchanova Z.P., Candy G.P., Wald A.M., Ngcezula T., Sareli P. Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension. S Afr Med J. 92:2002;532-536.
5. Skoulariges J., Strugo V., Chopamba A., Stekge S., Sareli P. Low dose hydrochlorothiazide (12.5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension assessment by ambulatory blood pressure monitoring. Am J Hypertens. 8:1995;1046-1050.
6. Borrow K.M., Newburger J.W. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow comparative study of indirect systolic, diastolic and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J. 103:1982;879-886.
7. O'Brien E., Mee F., Atkins N., O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. J Hypertens. 9:1991;573-574.
8. Sahn D.J., De Maria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurement. Circulation. 58:1978;1072-1083.
9. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol. 57:1986;450-458.
10. Emeriau J.P., Knauf H., Ocon Pujadas J., Calvo-Gomez C., Abate G., Leonetti G., Chastang C. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients a randomized double-blind controlled study. J Hypertens. 9:2001;343-349.
11. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium-channel blocker vs. diuretic the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 288:2002;2981-2997.